novo nordisk glp-1 weight loss launches its Wegovy Pill weight-loss drug to the US market, GoodRx discounts it Novo asks FDA to prevent

Common side effects of Wegovy (1 in 10 people) | Are there any dangerous weight loss injection side effects

Meet the winners and read about their accomplishments.

Panera introduces a "Metabolic Health" menu designed around blood sugar management

Start Your Weight Loss Transformation with Tirzepatide Injections in Pasadena, TX

Feel fuller, sooner

an investigational combination therapy being developed by Novo Nordisk that merges two powerful agents: (1) a long-acting amylin analog with a sequence to make it a calcitonin receptor agonist (2) a blockbuster GLP-1 receptor agonist ?via complementary hormonal pathways: mimics the natural hormone amylin, which is co-secreted with insulin